key: cord-0822954-1ah7t957
authors: Costa, Simonetta; Posteraro, Brunella; Marchetti, Simona; Tamburrini, Enrica; Carducci, Brigida; Lanzone, Antonio; Valentini, Piero; Buonsenso, Danilo; Sanguinetti, Maurizio; Vento, Giovanni; Cattani, Paola
title: Excretion of Sars-Cov-2 in human breastmilk samples
date: 2020-06-02
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.05.027
sha: 6b8f49ba21f91fcd1d50282a9173529ed02f7535
doc_id: 822954
cord_uid: 1ah7t957

nan

To the Editor,

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (Covid-19) [1] emerged in China since December 2019 and has rapidly spread to reach 3,023,788 confirmed cases over time, according to the World Health Organization report on 29 April 2020 (https://experience.arcgis.com/experience/685d0ace521648f8a5beeeee1b9125cd).

The SARS-CoV-2 is detectable in different body fluids, although human-to-human transmission mainly occurs by the respiratory route. Consistently, the virus is plausibly transmitted to neonates through infected mothers' respiratory droplets during breastfeeding [2] , but SARS-CoV-2 transmission may not occur through breastmilk [3, 4] .

In March 2020, we studied two pregnant women (thereafter referred to as patient 1 and patient 2) admitted to our hospital (Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, Italy) who received a laboratory-documented Covid-19 diagnosis (i.e., with nasopharyngeal swabs that were positive for SARS-CoV-2) [5] .

Patient 1 presented fever, shortness of breath, and diarrhoea and patient 2 cough (Table 1) . Both patients had a non-pneumonia disease. Laboratory investigations showed that lymphocyte were below the normal range (<1.0 × 10 9 cells per L) and C-reactive protein concentrations were elevated (>10 mg/L). The patients were in their third trimester and, eight days after Covid-19 diagnosis, underwent caesarean section following to foetal distress (patient 1, on 28 March 2020) or history of caesarean section (patient 2, on 26 March 2020). The patients were treated empirically with antimicrobial agents, and only patient 1 received oxygen support (nasal cannula) ( Table 1 ). The patient 1's neonate was born prematurely at 35 gestational age plus 5 days and had a birthweight lower than 2500 g. Both neonates were without or did not develop any clinical symptoms and, as a precaution, did not receive breastmilk.

We tested the presence of SARS-CoV-2 in amniotic fluid, cord blood, placental tissue, neonatal throat swab, and breastmilk (obtained on subsequent days after the caesarean section) samples in both patients, using reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays (Table 1) . In patient 1, we detected viral RNA in both placental tissue and cord blood samples and, importantly, in multiple breastmilk samples that were collected and tested after the first lactation (Table 1) . Three (50%) of six breastmilk samples had a cycle threshold value less than 40 (i.e., this is the value interpreted as positive for SARS-CoV-2 RNA), indicating that patient 1 excreted, albeit intermittently, virus in her breastmilk ( Figure S1 ). In patient 2, we did not detect viral RNA in none of the samples tested (Table 1) .

We showed the potentiality of mother-to-child transmission of the virus by extra-respiratory routes, suggesting that testing for SARS-CoV-2 in breastmilk samples could be of value to prevent neonatal infections. However, further studies on more women are needed to recommend such testing as part of routine evaluation of pregnant women with SARS-CoV-2 infection. Meanwhile, breastfeeding may not be practiced before a SARS-CoV-2 infected mother's isolation period is ended and viral clearance is assessed [4] . Aseptic cautions during breastmilk sample collection exclude the likelihood of contamination by mothers' respiratory droplets. Although we did not document SARS-CoV-2 infection in the neonate born from the mother with a positive RT-PCR result in the placenta, testing of intrauterine tissue samples may also be important [6] . To this regard, maternal-foetal transmission was suspected in 8 (4.5%) of 179 cases of neonates tested for SARS-CoV-2 at birth (5 with positive nasopharyngeal RT-PCR and 3 with specific IgM), who were born from pregnant women infected in the third trimester of pregnancy [7] . Anyway, all clinical samples testing positive for SARS-CoV-2 RNA should be assessed for live virus isolation, which is basilar to understand infectivity [8] but that was not performed in the present study.

In conclusion, we believe that investigations of pregnant women with Covid-19 symptoms should necessarily include testing from various body sites or fluids. This will help to improve the sensitivity and reduce false-negative test results.

The authors report no conflicts of interest relevant to this letter. The authors thank Reale Group and 

A novel coronavirus from patients with pneumonia in China

Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records

Can SARS-CoV-2-infected women breastfeed after viral clearance?

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry?

Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2

The authors are grateful to Franziska Lohmeyer for her English language assistance.

SC, BP, GV and PC worked on concept/design of the study; DB, PV, ET and BC worked on data collection; SM, PC and MS performed laboratory work; SC, BP and AL worked on data analysis/interpretation; MS acquired funding; SC, BP and MS drafted and critically revised the manuscript. All authors read and approved the final draft.